Patterns of Chemotherapy Utilization among Elderly Patients with Early-Stage Triple-Negative Breast Cancer

被引：0
|
作者：
Malinowski, Catalina
Lei, Xiudong
Giordano, Sharon
Chavez, Marianna
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO3-03-07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO3-03-07
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Immune checkpoint inhibition in early-stage triple-negative breast cancer
    Varma, Revati
    Wright, Matthew
    Abraham, Jame
    Kruse, Megan
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (11) : 1225 - 1238
  • [22] The Management of Early-Stage and Metastatic Triple-Negative Breast Cancer: A Review
    Anders, Carey K.
    Zagar, Timothy M.
    Carey, Lisa A.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2013, 27 (04) : 737 - +
  • [23] Real-world treatment patterns and effectiveness outcomes in patients with early-stage triple-negative breast cancer
    Haiderali, Amin
    Rhodes, Whitney C.
    Gautam, Santosh
    Huang, Min
    Sieluk, Jan
    Skinner, Karen E.
    Schwartzberg, Lee S.
    FUTURE ONCOLOGY, 2021, 17 (29) : 3819 - 3831
  • [24] National trends in neoadjuvant chemotherapy utilization in patients with early-stage node-negative triple-negative breast cancer: the impact of the CREATE-X trial
    Christine Rogers
    Adrienne N. Cobb
    Jan I. C. Lloren
    Lubna N. Chaudhary
    Morgan K. Johnson
    Chiang-Ching Huang
    Mediget Teshome
    Amanda L. Kong
    Puneet Singh
    Chandler S. Cortina
    Breast Cancer Research and Treatment, 2024, 203 : 317 - 328
  • [25] National trends in neoadjuvant chemotherapy utilization in patients with early-stage node-negative triple-negative breast cancer: the impact of the CREATE-X trial
    Rogers, Christine
    Cobb, Adrienne N.
    Lloren, Jan I. C.
    Chaudhary, Lubna N.
    Johnson, Morgan K.
    Huang, Chiang-Ching
    Teshome, Mediget
    Kong, Amanda L.
    Singh, Puneet
    Cortina, Chandler S.
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 203 (02) : 317 - 328
  • [26] Chemotherapy regimen choice and patient outcomes in early-stage triple-negative breast cancer: a retrospective analysis
    Ghafouri, Sanaz N.
    Nayeri, Rebecca W.
    McAndrew, Nicholas P.
    Hurvitz, Sara A.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [27] Capecitabine-based chemotherapy in early-stage triple-negative breast cancer: a meta-analysis
    Bai, Jie
    Yao, Xufeng
    Pu, Yinghong
    Wang, Xiaoyi
    Luo, Xinrong
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [28] Effectiveness of adjuvant chemotherapy for elderly patients with triple-negative breast cancer
    Guo, Qiusheng
    Lan, Tian
    Lu, Yunyan
    Hu, Zujian
    Xu, Haibin
    Wang, Xiaojia
    Shao, Xiying
    Fu, Xueyan
    BIOMOLECULES AND BIOMEDICINE, 2023, 23 (03): : 502 - 509
  • [29] Correlation of Snail expression and survival in patients with early-stage triple-negative breast cancer (TNBC)
    Jiralerspong, S.
    Liu, S.
    Palla, S. L.
    Mills, G. B.
    Hung, M.
    Hortobagyi, G. N.
    Gonzalez-Angulo, A. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [30] Prospect of neoadjuvant/adjuvant immunotherapy in early-stage triple-negative breast cancer
    Hao, Xiaopeng
    Gao, Xianqi
    Yin, Shanshan
    Jiang, Zefei
    TRANSLATIONAL BREAST CANCER RESEARCH, 2023, 4
12345